Advertisement

Covance Company Profile

23:20 EDT 24th May 2013 | BioPortfolio

Covance (NYSE: CVD), with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1 billion, global operations in 18 countries, and more than 7,000 employees worldwide.Worldwide, Covance helps pharmaceutical and biotech companies of all sizes fulfill their research and development, clinical trial, regulatory and marketing-support needs.

Location

210 Carnegie Center
Princeton
New Jersey
08540
United States of America

Contact

Phone: 1 888-Covance (268-2623


News Articles [ 88 Associated News Articles listed on BioPortfolio]

Covance Inc. Invites You to Join the Webcast of Its First Quarter 2013 Financial Results Conference Call

PRINCETON, N.J., April 3, 2013 /PRNewswire/ -- In conjunction with its first quarter 2013 earnings release (expected to be issued after market close on May 1, 2013), Covance Inc. (NYSE: CVD) is p...

Covance Inc. Invites You to Join the Webcast of Its Third Quarter 2012 Financial Results Conference Call

PRINCETON, N.J., Oct. 5, 2012 /PRNewswire/ -- In conjunction with its third quarter 2012 earnings release (expected to be issued after market close on November 5, 2012), Covance Inc. (NYSE: CVD)...

Covance Inc. Invites You to Join the Webcast of Its Second Quarter 2012 Financial Results Conference Call

PRINCETON, N.J., June 25, 2012 /PRNewswire/ -- In conjunction with its second quarter 2012 earnings release (expected to be issued after market close on July 25, 2012), Covance Inc. (NYSE: CVD) i...

Covance Inc. Invites You to Join the Webcast of Its Fourth Quarter 2012 Financial Results Conference Call

PRINCETON, N.J., Jan. 3, 2013 /PRNewswire/ -- In conjunction with its fourth quarter 2012 earnings release (expected to be issued after market close on January 24, 2013), Covance Inc. (NYSE: CVD)...

Bayer, Covance Enter Strategic Partnership

Will leverage Covance's clinical development experience and services

Bayer CRO consolidation sets up Covance for rise in revenue

Bayer could spend up to 50 per cent more with Covance after it cuts ties with its other late phase CRO partner.

GNS, Covance to develop models to predict development success

Data analytics company GNS Healthcare Inc. (Cambridge, Mass.) and CRO Covance Inc. (NYSE:CVD) partnered to develop computer models to predict the likelihood of a therapy's development success based on...

Covance Moves Further into Personalized Medicine with Collaboration

CRO Covance is teaming up with M2Gen’s cancer-focused database to increase its ability to match more patients in oncology trials based on their tumour profiles. 

Drugs and Medications [0 Results]

None

PubMed Articles [ 7 Associated PubMed Articles listed on BioPortfolio]

Safety and immunogenicity of a pneumococcal histidine triad protein D vaccine candidate in adults.

Pneumococcal vaccines based on conserved protein antigens have the potential to offer expanded protection against Streptococcus pneumoniae.

Teaching cross-cultural aspects of mourning: A Hindu perspective on death and dying.

Evaluation of a new column backflushing set-up in the gas chromatographic-tandem mass spectrometric analysis of pesticide residues in dietary supplements.

This study evaluated the use of a new concurrent backflushing set-up in the multiresidue analysis of pesticides in dietary supplement matrices using gas chromatography-tandem mass spectrometry (GC-MS/...

Liquid chromatography/tandem mass spectrometry sensitivity enhancement via online sample dilution and trapping: applications in microdosing and dried blood spot (DBS) bioanalysis.

A simple online sample dilution, enrichment, and cleanup technique was developed for sensitive microdosing and dried blood spot (DBS) liquid chromatography/tandem mass spectrometric (LC/MS/MS) bioanal...

(15)N chemical shifts of a series of isatin oxime ethers and their corresponding nitrone isomers.

In this article, we describe the characteristic (15)N chemical shifts of isatin oxime ethers and their isomer nitrone. These oxime ethers and nitrones are the alkylation reaction products of isatin ox...

Clinical Trials [0 Results]

None

Companies [ 8 Associated Companies listed on BioPortfolio]

Covance, Inc.

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1.7 billion, global ope...

Covance Bio

Covance Bio process development, phase I/II, and small scale cGMP manufacturing facility.

Covance

Covance (NYSE: CVD), with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1 billion,...

Covance UK

Covance is a global full service CRO. Services offered include: Strategic Consultancy, Programme Management, Regulatory advice, Quality assurance and audits, Toxicology, ADME studies, Safety pharmaco...

Covance Incorporated

Covance is a global full service CRO. Services offered include: Strategic Consultancy, Programme Management, Regulatory advice, Quality assurance and audits, Toxicology, ADME studies, Safety pharmaco...

More Information about "Covance" on BioPortfolio

We have published hundreds of Covance news stories on BioPortfolio along with dozens of Covance Clinical Trials and PubMed Articles about Covance for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Covance Companies in our database. You can also find out about relevant Covance Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement